Intensified neoadjuvant chemoradiotherapy (CRT) with capecitabine and irinotecan in patients with locally advanced rectal cancer (LARC): A phase I/II study.

被引：0
|
作者：
Klautke, G
Foitzik, T
Ludwig, K
Klar, EJM
Fietkau, R
机构：
[1] Univ Rostock, Rostock, Germany
[2] Klinikum Sudstadt, Rostock, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3693
引用
收藏
页码：292S / 292S
页数：1
相关论文
共 50 条
  • [41] Phase I trial of neoadjuvant concurrent chemoradiotherapy with S-1 and weekly irinotecan in locally advanced rectal cancer
    Ahn, J.
    Choi, H.
    Cheon, S.
    Shin, S.
    Keum, K.
    Min, B.
    Baik, S.
    Kim, N.
    Jeung, H.
    Roh, J.
    Chung, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [42] Neoadjuvant chemoradiotherapy with capecitabine in locally advanced rectal cancer: Analysis of prognostic factors
    Romero, Jesus
    Sanchez, Sofia
    Sanchez, Arsenio
    Alonso, Isabel
    Benlloch, Raquel
    Cordoba, Sofia
    Zapata, Irma
    Gil, Beatriz
    Lopez, Marta
    Hernandez, Maria
    Pastrana, Miguel
    Herreros, Alberto
    Casado, Ana Ruiz
    Obeso, Jorge
    Engel, Olga
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [43] Phase I study of trametinib and neoadjuvant chemoradiation (CRT) in patients with locally advanced rectal cancers (LARC) that harbor KRAS, BRAF, or NRAS mutations
    Wu, Christina Sing-Ying
    Williams, Terence Marques
    Wei, Lai
    Umar, Hamida
    Savysan, Arsen
    Mikhail, Sameh
    Ciombor, Kristen Keon
    Noonan, Anne M.
    Roychowdhury, Sameek
    El-Dika, Samer S.
    Krishna, Somashekar
    Upchurch, Bennie
    Arnold, Mark
    Harzman, Alan
    Abdel-Misih, Sherif
    Cirocco, William
    Bekaii-Saab, Tanios S.
    Wuthrick, Evan John
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [44] Phase I trial of neoadjuvant concurrent chemoradiotherapy with S-1 and weekly irinotecan in locally advanced rectal cancer
    Choi, Hye Jin
    Kim, Nam-Kyu
    Keum, Ki Chang
    Cheon, Seong Ha
    Shin, Sang Jun
    Baik, Seung Hyuk
    Choen, Jae Hee
    Rha, Sun Young
    Roh, Jae Kyung
    Jeung, Hei-Cheul
    Chung, Hyun Cheol
    Ahn, Joong Bae
    RADIOTHERAPY AND ONCOLOGY, 2008, 87 (03) : 361 - 366
  • [45] Systemic chemotherapy (CT) as salvage treatment for locally advanced rectal cancer (LARC) patients (pts) who fail to respond to neoadjuvant chemoradiotherapy (CRT).
    Sclafani, Francesco
    Brown, Gina
    Cunningham, David
    Rao, Sheela
    Tekkis, Paris P.
    Tait, Diana M.
    Morano, Federica
    Baratelli, Chiara
    Kalaitzaki, Eleftheria
    Rasheed, Shahnawaz
    Watkins, David J.
    Starling, Naureen
    Wotherspoon, Andrew
    Chau, Ian
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [46] Phase 1 Study of Trametinib and Neoadjuvant Chemoradiation (CRT) in Locally Advanced Rectal Cancer (LARC) with KRAS, BRAF, or NRAS Mutations
    Wuthrick, E. J.
    Williams, T. M.
    Wei, L.
    Umar, H.
    Savysan, A.
    Mikhail, S.
    Ciombor, K.
    Noonan, A.
    Roychowdhury, S.
    El-Dika, S.
    Krishna, S.
    Upchurch, B.
    Arnold, M.
    Harzman, A.
    Abdel-Misih, S.
    Cirocco, W.
    Bekaii-Saab, T.
    Wu, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S107 - S108
  • [47] A randomized phase II study of neoadjuvant chemoradiotherapy with 5-FU/leucovorin or irinotecan/S1 in patients with locally advanced rectal cancer
    Jung, Minkyu
    Shin, Sang Joon
    Lim, Seungtaek
    Park, Ji Soo
    Koom, Woong Sub
    Keum, Ki Chang
    Kim, Nam Kyu
    Back, Seung Hyuk
    Min, Byung Soh
    Hur, Hyuk
    Kim, Ho Geun
    Lim, Jun Seok
    Kim, Tae I. L.
    Roh, Jae Kyung
    Park, Young Suk
    Ahn, Joong Bae
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [48] Phase I/II Study of Preoperative Chemoradiotherapy With TEGAFIRI for Locally Advanced Rectal Cancer
    Kawai, Kazushige
    Sunami, Eiji
    Hata, Keisuke
    Tanaka, Toshiaki
    Nishikawa, Takeshi
    Otani, Kensuke
    Sasaki, Kazuhito
    Nozawa, Hiroaki
    CLINICAL COLORECTAL CANCER, 2018, 17 (03) : 240 - 246
  • [49] PHASE II TRIAL OF NEOADJUVANT BEVACIZUMAB, CAPECITABINE, AND RADIOTHERAPY FOR LOCALLY ADVANCED RECTAL CANCER
    Crane, Christopher H.
    Eng, Cathy
    Feig, Barry W.
    Das, Prajnan
    Skibber, John M.
    Chang, George J.
    Wolff, Robert A.
    Krishnan, Sunil
    Hamilton, Stanley
    Janjan, Nora A.
    Maru, Dipen M.
    Ellis, Lee M.
    Rodriguez-Bigas, Miguel A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 76 (03): : 824 - 830
  • [50] Phase II study with oral capecitabine (XELODA®) as a radiosensitiser in neoadjuvant treatment of locally advanced rectal cancer
    Velenik, V.
    Anderluh, F.
    Oblak, I.
    Strojan, P.
    Zakotnik, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S289 - S289
12345